Veterinary Medicines

HEPTAVAC IRP suspensie injectabilă pentru oi

Authorised
  • Clostridium perfringens, type C, beta toxoid
  • Clostridium perfringens, type D, epsilon toxoid
  • Clostridium septicum, toxoid
  • Clostridium tetani, toxoid
  • Clostridium novyi, toxoid
  • Clostridium chauvoei, Inactivated
  • Mannheimia haemolytica, serotype A1, Inactivated
  • Mannheimia haemolytica, serotype A2, Inactivated
  • Mannheimia haemolytica, serotype A6, Inactivated
  • Mannheimia haemolytica, serotype A7, Inactivated
  • Mannheimia haemolytica, serotype A9, Inactivated
  • Bibersteinia trehalosi, serotype T3, Inactivated
  • Bibersteinia trehalosi, serotype T4, Inactivated
  • Bibersteinia trehalosi, serotype T10, Inactivated
  • Bibersteinia trehalosi, serotype T15, Inactivated
Download as PDF

Product identification

Medicine name:
HEPTAVAC IRP suspensie injectabilă pentru oi
Active substance:
  • Clostridium perfringens, type C, beta toxoid
  • Clostridium perfringens, type D, epsilon toxoid
  • Clostridium septicum, toxoid
  • Clostridium tetani, toxoid
  • Clostridium novyi, toxoid
  • Clostridium chauvoei, Inactivated
  • Mannheimia haemolytica, serotype A1, Inactivated
  • Mannheimia haemolytica, serotype A2, Inactivated
  • Mannheimia haemolytica, serotype A6, Inactivated
  • Mannheimia haemolytica, serotype A7, Inactivated
  • Mannheimia haemolytica, serotype A9, Inactivated
  • Bibersteinia trehalosi, serotype T3, Inactivated
  • Bibersteinia trehalosi, serotype T4, Inactivated
  • Bibersteinia trehalosi, serotype T10, Inactivated
  • Bibersteinia trehalosi, serotype T15, Inactivated
Target species:
  • Sheep
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Clostridium perfringens, type C, beta toxoid
    10.00
    unit(s)
    /
    1.00
    millilitre(s)
  • Clostridium perfringens, type D, epsilon toxoid
    5.00
    unit(s)
    /
    1.00
    millilitre(s)
  • Clostridium septicum, toxoid
    2.50
    unit(s)
    /
    1.00
    millilitre(s)
  • Clostridium tetani, toxoid
    2.50
    unit(s)
    /
    1.00
    millilitre(s)
  • Clostridium novyi, toxoid
    3.50
    unit(s)
    /
    1.00
    millilitre(s)
  • Clostridium chauvoei, Inactivated
    90.00
    Relative Percentage Survival
    /
    1.00
    millilitre(s)
  • Mannheimia haemolytica, serotype A1, Inactivated
    8.70
    log10 colony forming unit(s)
    /
    1.00
    millilitre(s)
  • Mannheimia haemolytica, serotype A2, Inactivated
    8.70
    log10 colony forming unit(s)
    /
    1.00
    millilitre(s)
  • Mannheimia haemolytica, serotype A6, Inactivated
    8.70
    log10 colony forming unit(s)
    /
    1.00
    millilitre(s)
  • Mannheimia haemolytica, serotype A7, Inactivated
    8.70
    log10 colony forming unit(s)
    /
    1.00
    millilitre(s)
  • Mannheimia haemolytica, serotype A9, Inactivated
    8.70
    log10 colony forming unit(s)
    /
    1.00
    millilitre(s)
  • Bibersteinia trehalosi, serotype T3, Inactivated
    8.70
    log10 colony forming unit(s)
    /
    1.00
    millilitre(s)
  • Bibersteinia trehalosi, serotype T4, Inactivated
    8.70
    log10 colony forming unit(s)
    /
    1.00
    millilitre(s)
  • Bibersteinia trehalosi, serotype T10, Inactivated
    8.70
    log10 colony forming unit(s)
    /
    1.00
    millilitre(s)
  • Bibersteinia trehalosi, serotype T15, Inactivated
    8.70
    log10 colony forming unit(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Sheep
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI04AB05
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Romania
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Complete application (stand-alone) - Directive No 2001/82/EC
Marketing authorisation holder:
  • Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Intervet International B.V.
Responsible authority:
  • Institute For Control Of Biological Products And Veterinary Medicines
Authorisation number:
  • 170027
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Romanian (PDF)
Published on: 23/01/2024
Download